Premed · Premed · Immunology
Lecture 19: Germinal Center Reactions and Affinity Maturation
Immunology
Learning Objectives
By the end of this lecture, students will be able to:
- Describe the structure and cellular composition of the germinal center
- Explain the process of somatic hypermutation and its role in affinity maturation
- Describe the selection process for high-affinity B cells within the germinal center
- Explain the molecular mechanisms of class switch recombination (CSR)
- Describe the differentiation of germinal center B cells into plasma cells and memory B cells
Lecture Content
I. Germinal Center Formation
Germinal centers (GCs) are transient microanatomical structures that form within B cell follicles of secondary lymphoid organs following T-dependent immune responses. They begin forming 5 to 7 days after antigen exposure, peak at 2 to 3 weeks, and can persist for weeks to months. GC formation is initiated when activated B cells that have received T cell help at the T-B border migrate into the follicle and begin proliferating at an extraordinary rate -- with a cell cycle time of just 6 to 8 hours, they are among the fastest-dividing cells in the body. These rapidly proliferating B cells displace the resting naive B cells that normally occupy the follicle. Follicular dendritic cells (FDCs), which are stromal cells not derived from the hematopoietic lineage, provide essential structural and functional support within the GC.
T follicular helper (Tfh) cells are the specialized CD4+ T cell subset essential for GC reactions. They express BCL6 (their master transcription factor), CXCR5 (which directs them to follicles), PD-1, ICOS, and CD40L. Tfh cells produce IL-21, the primary cytokine driving GC B cell proliferation and differentiation, as well as IL-4. Importantly, Tfh cells are a limiting resource within the GC -- B cells must compete for their help, and this competition forms the basis for affinity-based selection.
II. Germinal Center Architecture
The mature GC is organized into two functionally distinct zones. The dark zone (DZ) is densely packed with rapidly proliferating B cells called centroblasts. This is where somatic hypermutation occurs. Centroblasts express CXCR4, which retains them in the DZ through attraction to CXCL12 produced by DZ stromal cells. Cell division in the DZ is accompanied by a high rate of apoptosis, as many mutations are deleterious.
The light zone (LZ) is less dense and contains centrocytes (non-dividing B cells testing their mutated receptors), Tfh cells, and FDCs. FDCs display antigen in the form of immune complexes (antigen-antibody-complement) on their long dendritic processes. Centrocytes express CXCR5, which retains them in the LZ through attraction to CXCL13 produced by FDCs. In the LZ, centrocytes test their mutated BCRs against antigen on FDCs, competing for limited T cell help.
A defining feature of GC biology is cyclic re-entry: B cells shuttle between the dark and light zones multiple times. In each cycle, they mutate in the DZ, test their affinity in the LZ, and if selected, return to the DZ for further rounds of mutation. This iterative process, typically involving 3 to 4 cycles of mutation and selection, progressively refines the antibody response.
<image>A cross-sectional diagram of a germinal center within a lymph node follicle. The germinal center is divided into two zones: the dark zone (DZ, darker shading) and the light zone (LZ, lighter shading). In the DZ, densely packed centroblasts are shown undergoing rapid proliferation and somatic hypermutation, with AID enzyme acting on immunoglobulin variable region genes. CXCL12 is shown being produced by DZ stromal cells, attracting CXCR4+ centroblasts. In the LZ, centrocytes are shown interacting with follicular dendritic cells (FDCs) that display immune complexes (antigen-antibody-C3d) on long dendritic processes. Tfh cells in the LZ provide help to centrocytes via CD40L-CD40 and secrete IL-21. Arrows show the cyclic migration: centroblasts (CXCR4+) → centrocytes (CXCR5+) moving from DZ to LZ, and selected centrocytes returning to DZ. Exit pathways show centrocytes differentiating into memory B cells or plasmablasts leaving the GC. The mantle zone of naive IgD+ B cells surrounds the GC.</image>
III. Somatic Hypermutation (SHM)
Somatic hypermutation is the introduction of point mutations at an extraordinarily high frequency -- approximately 10^-3 per base pair per cell division -- in the variable regions of rearranged immunoglobulin genes. SHM occurs exclusively in GC centroblasts in the dark zone and is entirely dependent on activation-induced cytidine deaminase (AID), the same enzyme responsible for class switch recombination.
AID deaminates cytosine to uracil in single-stranded DNA that is exposed during transcription of immunoglobulin genes. The resulting uracils are then processed by downstream repair pathways that introduce diverse mutations. Replication over the uracil produces C:G to T:A transitions. Removal of uracil by uracil-DNA glycosylase (UNG) creates abasic sites that are filled by error-prone translesion synthesis, generating a variety of mutations. Mismatch repair by MSH2/MSH6 leads to excision and error-prone resynthesis, extending mutations to A:T base pairs. Mutations are concentrated in WRCY/RGYW hotspot motifs (where W = A/T, R = purine, Y = pyrimidine).
The result is that each centroblast daughter cell acquires a unique set of approximately 5 to 10 mutations per variable region per cell division. Most of these mutations are deleterious -- reducing affinity or producing a non-functional BCR -- and cells bearing such mutations die by apoptosis. Only the rare mutations that improve antigen-binding affinity confer a survival advantage, and cells carrying these beneficial mutations are positively selected in the light zone.
IV. Affinity Maturation and Selection
Affinity maturation is the progressive increase in the average affinity of antibodies produced during a T-dependent immune response, and it is the direct consequence of iterative cycles of somatic hypermutation and selection in the germinal center.
The selection mechanism in the light zone proceeds as follows. Centrocytes with mutated BCRs compete for limited antigen displayed on FDCs. Those with higher-affinity BCRs capture more antigen, internalize it, process it, and present more peptide-MHC class II complexes on their surface. Centrocytes presenting more peptide-MHC II receive stronger and longer-duration Tfh cell help through CD40L and IL-21. This help delivers survival signals, including upregulation of Bcl-2 and Bcl-xL, rescuing the cell from the default pathway of apoptosis. Cells that fail to capture sufficient antigen or receive inadequate Tfh help undergo apoptosis by death by neglect.
Competition is the key principle: because Tfh cells are limiting, only the highest-affinity B cells receive enough help to survive. Over successive rounds of mutation and selection, the antibody response becomes progressively more refined. Primary response IgG typically exhibits a dissociation constant (Kd) in the range of 10^-7 to 10^-9 M, while after extensive affinity maturation the Kd can reach 10^-10 to 10^-11 M.
<image>A step-by-step diagram of the affinity maturation process. Panel 1: In the dark zone, a centroblast is shown with AID acting on the V region gene. Daughter cells are produced with different mutations (shown as stars on the BCR), resulting in BCRs of varying affinities (high, medium, low, non-functional). Panel 2: Centrocytes migrate to the light zone and test their BCRs against antigen on FDC surfaces. High-affinity cells capture abundant antigen (large endosomal vesicles), medium-affinity cells capture less, and low-affinity or non-functional cells capture little or none. Panel 3: Centrocytes present processed peptide on MHC II to Tfh cells. High-affinity cells (presenting more pMHC II) form stable conjugates with Tfh cells and receive strong CD40L/IL-21 signals. Low-affinity cells fail to engage Tfh cells and undergo apoptosis (shown as fragmented cells being cleared by tingible body macrophages). Panel 4: Selected high-affinity cells either re-enter the dark zone for further rounds of mutation or exit as memory B cells/plasma cell precursors.</image>
V. Class Switch Recombination (CSR)
Class switch recombination is the irreversible change of the antibody heavy chain constant region from C-mu (IgM) to C-gamma, C-alpha, or C-epsilon (IgG, IgA, or IgE). CSR occurs in GC B cells and, to some extent, in extrafollicular responses.
The mechanism relies on switch (S) regions -- repetitive DNA sequences located upstream of each constant region gene except C-delta. AID deaminates cytosines in the donor S-mu region and a target downstream S region. Processing of these uracils generates double-strand breaks (DSBs) in both switch regions. The intervening DNA between S-mu and the target switch region is looped out and deleted as a circular excision product, and the broken ends are joined by non-homologous end joining (NHEJ), creating an S-mu-S-x hybrid junction. The VDJ exon is now directly upstream of a new constant region gene, producing an antibody with the same antigen specificity but a different isotype and therefore different effector functions.
The direction of switching is controlled by cytokines from Tfh cells and other sources that induce germline transcription through specific switch regions, opening the chromatin and making it accessible to AID. IL-4 directs switching to IgG1 and IgE (via STAT6-driven germline transcription of C-gamma-1 and C-epsilon). IFN-gamma directs switching to IgG2a and IgG3 -- the complement-fixing, opsonizing isotypes characteristic of Th1 responses. TGF-beta promotes switching to IgA (for mucosal immunity) and IgG2b. IL-21 drives IgG1 and IgG3 switching in a context-dependent manner, and IL-5 enhances IgA production. CD40 signaling is absolutely required for CSR -- without it, as in Hyper-IgM syndrome caused by CD40L deficiency, neither CSR nor GC formation occurs.
VI. Differentiation of GC B Cells
Selected GC B cells face two major fates. High-affinity B cells that receive strong T cell help and antigen signals differentiate into plasma cells. This process is driven by Blimp-1 (PRDM1), the master transcription factor for plasma cell differentiation, which represses BCL6 and PAX5 (genes maintaining GC and B cell identity) and activates XBP1, which triggers the unfolded protein response and expansion of the ER to accommodate massive antibody secretion. IRF4 at high levels drives Blimp-1 expression and the plasma cell program. Plasmablasts exit the GC and migrate to the bone marrow, where they occupy survival niches sustained by APRIL, BAFF, IL-6, and CXCL12. These long-lived plasma cells can secrete antibody for decades, providing the basis for long-term serological immunity. Short-lived plasma cells are also generated in extrafollicular foci as part of the early response.
Lower-affinity selected cells that receive moderate T cell help may preferentially become memory B cells. These cells express high-affinity, class-switched BCRs but do not secrete antibody. They recirculate through secondary lymphoid organs and tissues, poised for rapid reactivation upon antigen re-encounter. During secondary responses, memory B cells can re-enter germinal centers for additional rounds of affinity maturation, generating an even more refined antibody response.
<image>A diagram of class switch recombination (CSR). The top shows the immunoglobulin heavy chain locus after V(D)J recombination: VDJ-Smu-Cmu-Cdelta-Sgamma3-Cgamma3-Sgamma1-Cgamma1-Salpha1-Calpha1-Sgamma2-Cgamma2-Sgamma4-Cgamma4-Sepsilon-Cepsilon-Salpha2-Calpha2. AID is shown acting on the Smu and Sgamma1 switch regions (directed by IL-4-induced germline transcription through Cgamma1). Double-strand breaks are introduced in both S regions. The intervening DNA (Cmu, Cdelta, Sgamma3, Cgamma3) is looped out and deleted as a circular excision product. The final locus shows VDJ joined directly to Cgamma1 via an Smu-Sgamma1 hybrid junction. The resulting B cell now expresses IgG1 with the same VDJ (same antigen specificity). A side panel shows different cytokines directing switching to different isotypes: IL-4 → IgE (Sepsilon-Cepsilon), IFN-gamma → IgG2a, TGF-beta → IgA.</image>
VII. Clinical Correlations
Several clinical conditions illustrate the importance of germinal center biology. Hyper-IgM syndromes arise from defects in the molecular machinery of CSR and SHM. The X-linked form (most common) results from CD40L deficiency, preventing CSR and GC formation. AID deficiency causes an autosomal recessive form with absent SHM and CSR, resulting in elevated IgM but no IgG, IgA, or IgE. UNG deficiency produces a similar but milder phenotype.
Aberrant GC responses can generate high-affinity self-reactive antibodies, contributing to autoimmune disease. In systemic lupus erythematosus (SLE), dysregulated GC reactions produce anti-dsDNA and anti-nuclear antibodies that drive tissue damage. GC biology also intersects with cancer: AID-mediated off-target mutations can cause chromosomal translocations. Follicular lymphoma results from translocation of BCL2 to the IgH locus, preventing GC B cells from undergoing apoptosis, while Burkitt lymphoma arises from translocation of c-MYC to the IgH locus.
